Cargando…

An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid

Stroke is the second leading cause of death after heart disease globally and cerebral ischemic stroke accounts for approximately 70% of all incident stroke cases. We selected four main compounds from a patent Chinese medicine, Qingkailing (QKL) injection, including baicalin from Scutellaria baicalen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Chongyang, Wang, Xueqian, Xu, Tian, Zhang, Shuang, Liu, Shuling, Zhai, Changming, Wang, Zisong, Mu, Jie, Li, Changxiang, Cheng, Fafeng, Wang, Qingguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227481/
https://www.ncbi.nlm.nih.gov/pubmed/32457601
http://dx.doi.org/10.3389/fphar.2020.00519
_version_ 1783534504863858688
author Ma, Chongyang
Wang, Xueqian
Xu, Tian
Zhang, Shuang
Liu, Shuling
Zhai, Changming
Wang, Zisong
Mu, Jie
Li, Changxiang
Cheng, Fafeng
Wang, Qingguo
author_facet Ma, Chongyang
Wang, Xueqian
Xu, Tian
Zhang, Shuang
Liu, Shuling
Zhai, Changming
Wang, Zisong
Mu, Jie
Li, Changxiang
Cheng, Fafeng
Wang, Qingguo
author_sort Ma, Chongyang
collection PubMed
description Stroke is the second leading cause of death after heart disease globally and cerebral ischemic stroke accounts for approximately 70% of all incident stroke cases. We selected four main compounds from a patent Chinese medicine, Qingkailing (QKL) injection, including baicalin from Scutellaria baicalensis Georgi (Huang Qin), geniposide from Gardenia jasminoides J. Ellis (Zhizi), and cholic acid and hyodeoxycholic acid from Bovis Calculus (Niuhuang) with a ratio of 4.4:0.4:3:2.6 m/m, to develop a more efficacious and safer modern Chinese medicine injection against ischemic stroke, refined QKL (RQKL). In this study, we investigated multiple targets, levels, and pathways of RQKL by using an integrative pharm\acology combining experimental validation approach. In silica study showed that RQKL may regulate PI3K-Akt, estrogen, neurotrophin, HIF-1, MAPK, Hippo, FoxO, TGF-beta, NOD-like receptor, apoptosis, NF-kappa B, Wnt, chemokine, TNF, Toll-like receptor signaling pathways against ischemic stroke. The experimental results showed that RQKL improved neurological function and prevented infract volume and blood-brain-barrier damage. RQKL inhibited microgliosis and astrogliosis, and protected neurons from ischemic/reperfusion injury. RQKL also inhibited cell apoptosis and affecting the ratio of the anti-apoptosis protein B-cell lymphoma-2 (Bcl2) and pro-apoptosis protein Bcl2-associated X protein (Bax). Western blot analysis showed that RQKL activated AKT/PI3K signaling pathway and antibody array showed RQKL inhibited inflammatory response and decreased proinflammatory factor Tnf, Il6, and Il1b, and chemokines Ccl2, Cxcl2, and Cxcl3, and increased anti-inflammatory cytokine Il10. In conclusion, RQKL protected tissue against ischemic stroke through multiple-target, multiple signals, and modulating multiple cell-types in brain. This study not only promoted our understanding of the role of RQKL against ischemic stroke, but also provided a pattern for the study of Chinese medicine combining pharmaceutical Informatics and system biology methods.
format Online
Article
Text
id pubmed-7227481
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72274812020-05-25 An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid Ma, Chongyang Wang, Xueqian Xu, Tian Zhang, Shuang Liu, Shuling Zhai, Changming Wang, Zisong Mu, Jie Li, Changxiang Cheng, Fafeng Wang, Qingguo Front Pharmacol Pharmacology Stroke is the second leading cause of death after heart disease globally and cerebral ischemic stroke accounts for approximately 70% of all incident stroke cases. We selected four main compounds from a patent Chinese medicine, Qingkailing (QKL) injection, including baicalin from Scutellaria baicalensis Georgi (Huang Qin), geniposide from Gardenia jasminoides J. Ellis (Zhizi), and cholic acid and hyodeoxycholic acid from Bovis Calculus (Niuhuang) with a ratio of 4.4:0.4:3:2.6 m/m, to develop a more efficacious and safer modern Chinese medicine injection against ischemic stroke, refined QKL (RQKL). In this study, we investigated multiple targets, levels, and pathways of RQKL by using an integrative pharm\acology combining experimental validation approach. In silica study showed that RQKL may regulate PI3K-Akt, estrogen, neurotrophin, HIF-1, MAPK, Hippo, FoxO, TGF-beta, NOD-like receptor, apoptosis, NF-kappa B, Wnt, chemokine, TNF, Toll-like receptor signaling pathways against ischemic stroke. The experimental results showed that RQKL improved neurological function and prevented infract volume and blood-brain-barrier damage. RQKL inhibited microgliosis and astrogliosis, and protected neurons from ischemic/reperfusion injury. RQKL also inhibited cell apoptosis and affecting the ratio of the anti-apoptosis protein B-cell lymphoma-2 (Bcl2) and pro-apoptosis protein Bcl2-associated X protein (Bax). Western blot analysis showed that RQKL activated AKT/PI3K signaling pathway and antibody array showed RQKL inhibited inflammatory response and decreased proinflammatory factor Tnf, Il6, and Il1b, and chemokines Ccl2, Cxcl2, and Cxcl3, and increased anti-inflammatory cytokine Il10. In conclusion, RQKL protected tissue against ischemic stroke through multiple-target, multiple signals, and modulating multiple cell-types in brain. This study not only promoted our understanding of the role of RQKL against ischemic stroke, but also provided a pattern for the study of Chinese medicine combining pharmaceutical Informatics and system biology methods. Frontiers Media S.A. 2020-05-08 /pmc/articles/PMC7227481/ /pubmed/32457601 http://dx.doi.org/10.3389/fphar.2020.00519 Text en Copyright © 2020 Ma, Wang, Xu, Zhang, Liu, Zhai, Wang, Mu, Li, Cheng and Wang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Ma, Chongyang
Wang, Xueqian
Xu, Tian
Zhang, Shuang
Liu, Shuling
Zhai, Changming
Wang, Zisong
Mu, Jie
Li, Changxiang
Cheng, Fafeng
Wang, Qingguo
An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid
title An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid
title_full An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid
title_fullStr An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid
title_full_unstemmed An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid
title_short An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid
title_sort integrative pharmacology-based analysis of refined qingkailing injection against cerebral ischemic stroke: a novel combination of baicalin, geniposide, cholic acid, and hyodeoxycholic acid
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227481/
https://www.ncbi.nlm.nih.gov/pubmed/32457601
http://dx.doi.org/10.3389/fphar.2020.00519
work_keys_str_mv AT machongyang anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT wangxueqian anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT xutian anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT zhangshuang anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT liushuling anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT zhaichangming anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT wangzisong anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT mujie anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT lichangxiang anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT chengfafeng anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT wangqingguo anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT machongyang integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT wangxueqian integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT xutian integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT zhangshuang integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT liushuling integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT zhaichangming integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT wangzisong integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT mujie integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT lichangxiang integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT chengfafeng integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid
AT wangqingguo integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid